Document Detail


Isradipine and insulin sensitivity in hypertensive rats.
MedLine Citation:
PMID:  10362616     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present study was designed to investigate the effect of a reduction in blood pressure, by using the calcium channel antagonist isradipine, on insulin sensitivity and vascular responses to insulin in conscious spontaneously hypertensive male rats (SHR). The rats were instrumented with intravascular catheters and pulsed Doppler flow probes to measure blood pressure, heart rate, and blood flows. Insulin sensitivity was assessed by the euglycemic-hyperinsulinemic clamp technique. Two groups of rats received isradipine at a dose of 0.05 or 0.15 mg. kg-1. h-1, whereas a third group received a continuous infusion of vehicle (15% DMSO). Both doses of isradipine were found to decrease mean blood pressure (-25 +/- 4 mmHg at the dose of 0.05 mg. kg-1. h-1 and -20 +/- 2 mmHg at the dose of 0.15 mg. kg-1. h-1) and to improve insulin sensitivity. Moreover, in the rats treated with the low dose of isradipine, we observed vasodilations in renal, superior mesenteric, and hindquarter vascular beds. In the untreated group, the euglycemic infusion of insulin (4 mU. kg-1. min-1) was found to cause vasoconstrictions in superior mesenteric and hindquarter vascular beds, but no changes in mean blood pressure, heart rate, or renal vascular conductance were found. In contrast, in the isradipine-treated groups, the same dose of insulin was found to produce vasodilations in the renal vascular bed and to abolish the vasoconstrictor responses previously observed. We concluded that short-term treatment with isradipine in SHR can lower blood pressure and improve insulin sensitivity, mainly through hemodynamic factors, as supported by experiments with hydralazine as a positive vasodilator control.
Authors:
M Pĭtre; N Gaudreault; M Santuré; A Nadeau; H Bachelard
Related Documents :
2437396 - Effect of inhibition of central angiotensin pressor mechanisms on blood pressure in spo...
8382236 - Membrane microviscosity does not correlate with blood pressure: a cosegregation study.
10930186 - Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats.
17959026 - Effects of combination therapy with atenolol and amlodipine on blood pressure control a...
7380616 - Behavioral versus pharmacological treatments for essential hypertension: a pilot study.
22011836 - Echocardiography based estimation of pulmonary vascular resistance in patients with pul...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of physiology     Volume:  276     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-07-29     Completed Date:  1999-07-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  E1038-48     Citation Subset:  IM    
Affiliation:
Hypertension Research Unit, Laval University Medical Research Center, Centre Hospitalier de l'Université, Laval University, Ste-Foy, Quebec, Canada G1V 4G2.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects
Calcium Channel Blockers / pharmacology*
Dose-Response Relationship, Drug
Glucose Clamp Technique
Hemodynamics / drug effects
Hydralazine / pharmacology
Hypertension / physiopathology*
Insulin / physiology*
Isradipine / pharmacology*
Male
Rats
Rats, Inbred SHR
Renal Circulation / drug effects
Vasoconstrictor Agents / pharmacology
Vasodilator Agents / pharmacology
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers; 0/Vasoconstrictor Agents; 0/Vasodilator Agents; 11061-68-0/Insulin; 75695-93-1/Isradipine; 86-54-4/Hydralazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo.
Next Document:  Effect of GIP and GLP-1 antagonists on insulin release in the rat.